Travoprost

drugbox
IUPAC_name = propan-2-yl 7- [3,5-dihydroxy-2- [3-hydroxy-4- [3-(trifluoromethyl)
phenoxy] -but-1-enyl] -cyclopentyl] hept-5-enoate

---

CAS_number = 157283-68-6
ATC_prefix = S01
ATC_suffix = EE04
ATC_supplemental =
PubChem = 656627
DrugBank = APRD01271
C = 26 | H = 35 | F = 3 | O = 6
molecular_weight = 500.548 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category = C US
legal_AU =
legal_UK =
legal_US =
legal_status = Rx only (US)
routes_of_administration = Topical (eye drops)

Travoprost ophthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension, by reducing intraocular pressure. It is a prostaglandin analogue that works by increasing the outflow of aqueous fluid from the eyes. [ [http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/500293.html] ] It is also known by the brand name of Travatan, manufactured by Alcon Inc.Travoprost is a synthetic prostaglandin F 2α analogue. Its chemical name is isopropyl (Z)-7- [(1 R ,2 R ,3 R ,5 S )-3,5-dihydroxy-2- [(1 E ,3 R )-3-hydroxy-4- [(α,α,α-trifluoro- m -tolyl)oxy] -1- butenyl] cyclopentyl] -5-heptenoate. [ [http://www.rxlist.com/cgi/generic2/travoprost.htm Travatan (Travoprost) drug description - FDA approved labeling for prescription drugs and medications at RxList ] ]

ide effects

Possible side effects of this medication are:
* May cause blurred vision;
* May cause eyelid redness;
* May permanently darken eyelashes;
* May cause eye discomfort;
* May eventually cause permanent darkening of the iris to brown (heterochromia);
* May cause a temporary burning sensation during use.
* May cause thickening of the eyelashes.

References

* http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/500293.html

Notes